Showing 26–50 of 60 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | Liver Cancer ISSN: 2235-1795 / 1664-5553Top Tier | 🇨🇭Switzerland | Q1 | CAS Tier 1 | 10.5 | 3.334Q1 | 25 | 50 | 7.8% | S. Karger AG | Profile |
| 27 | npj Precision Oncology ISSN: 2397-768XTop Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 1 | 9.9 | 3.616Q1 | — | 99 | 2.9% | Springer Nature | Profile |
| 28 | Cancer Immunology Research ISSN: 2326-6066 / 2326-6074Top Tier | 🇺🇸United States | Q1 | CAS Tier 1 | 7.9 | 3.48Q1 | 62 | 111 | 2.5% | American Association for Cancer Research Inc. | Profile |
| 29 | European Journal of Cancer ISSN: 0959-8049 / 1879-0852Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 1 | 7.9 | 2.692Q1 | 193 | 436 | 2.6% | Elsevier Ltd | Profile |
| 30 | British Journal of Cancer ISSN: 0007-0920 / 1532-1827Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 1 | 7.8 | 2.803Q1 | 212 | 376 | 1.6% | Springer Nature | Profile |
| 31 | Jnci-Journal of the National Cancer Institute ISSN: 0027-8874 / 1460-2105Top Tier | 🇺🇸United States | Q1 | CAS Tier 1 | 7.7 | 3.786Q1 | 333 | 198 | 3% | Oxford University Press | Profile |
| 32 | International Journal of Oncology ISSN: 1019-6439 / 1791-2423 | 🌐Greece | Q1 | CAS Tier 2 | 7.3 | 1.408Q1 | 111 | 124 | 0% | Spandidos Publications | Profile |
| 33 | Cancer Cell International ISSN: 1475-2867Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 7 | 1.75Q1 | 47 | 670 | 0% | BioMed Central | Profile |
| 34 | Molecular Cancer Therapeutics ISSN: 1535-7163 / 1538-8514Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 6.9 | 2.392Q1 | 157 | 230 | 0% | American Association for Cancer Research Inc. | Profile |
| 35 | Seminars in Oncology ISSN: 0093-7754 / 1532-8708Top Tier | 🇺🇸United States | Q1 | CAS Tier 4 | 6.8 | 1.536Q1 | 125 | 33 | 3.3% | W.B. Saunders Ltd | Profile |
| 36 | Chinese Journal of Cancer Research ISSN: 1000-9604 / 1993-0631 | 🇨🇳China | Q1 | CAS Tier 1 | 6.7 | 1.406Q1 | — | 62 | 14.3% | Springer Berlin Heidelberg | Profile |
| 37 | Breast Cancer Research ISSN: 1465-542X / 1465-5411 | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 6.2 | — | 126 | 108 | 1.6% | BioMed Central | Profile |
| 38 | Breast Cancer Research ISSN: 1465-5411 / 1465-542X | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 6.2 | 1.907Q1 | 132 | 108 | 1.6% | BioMed Central | Profile |
| 39 | Oncoimmunology ISSN: 2162-4011 / 2162-402XTop Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 6.2 | 2.438Q1 | 58 | 218 | 3.1% | Landes Bioscience | Profile |
| 40 | Oncogenesis ISSN: 2157-9024 | 🇺🇸United States | Q1 | CAS Tier 2 | 6 | 2.081Q1 | 31 | 78 | 1.7% | Springer Nature | Profile |
| 41 | Current Treatment Options in Oncology ISSN: 1527-2729 / 1534-6277Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 5.8 | 1.626Q1 | 48 | 114 | 0% | Springer US | Profile |
| 42 | Cancer Biology & Therapy ISSN: 1538-4047 / 1555-8576 | 🇺🇸United States | Q1 | CAS Tier 2 | 5.7 | 1.407Q1 | 101 | 51 | 0% | Landes Bioscience | Profile |
| 43 | Clinical Epigenetics ISSN: 1868-7083 / 1868-7075Top Tier | 🇬🇧United Kingdom | Q1 | CAS Tier 2 | 5.7 | — | 39 | 208 | 4.2% | BioMed Central | Profile |
| 44 | Cancer ISSN: 0008-543X / 1097-0142Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 5.6 | 2.427Q1 | 277 | 435 | 1.6% | John Wiley and Sons Inc. | Profile |
| 45 | Jco Oncology Practice ISSN: 2688-1527 / 2688-1535 | 🇺🇸United States | Q1 | CAS Tier 2 | 5.5 | 1.985Q1 | — | 227 | 6.4% | LIPPINCOTT WILLIAMS & WILKINS | Profile |
| 46 | Current Oncology Reports ISSN: 1523-3790 / 1534-6269Top Tier | 🇺🇸United States | Q1 | CAS Tier 2 | 5.2 | 1.595Q1 | 52 | 139 | 0% | Springer US | Profile |
| 47 | Targeted Oncology ISSN: 1776-2596 / 1776-260X | 🇫🇷France | Q1 | CAS Tier 2 | 5.1 | 1.435Q1 | 35 | 67 | 2.3% | Springer International Publishing | Profile |
| 48 | International Journal of Cancer ISSN: 0020-7136 / 1097-0215Top Tier | 🇨🇭Switzerland | Q2 | CAS Tier 2 | 4.9 | 1.901Q1 | 212 | 370 | 1.8% | Wiley-Liss Inc. | Profile |
| 49 | Cancer Imaging ISSN: 1470-7330 | 🇬🇧United Kingdom | Q2 | CAS Tier 2 | 4.8 | 1.16Q1 | 40 | 66 | 2.9% | BioMed Central | Profile |
| 50 | Neoplasia ISSN: 1522-8002 / 1476-5586 | 🇺🇸United States | Q2 | CAS Tier 2 | 4.8 | — | 117 | 111 | 1.6% | Neoplasia Press | Profile |